2024-02-07 17:51:05 ET
Vanda Pharmaceuticals Inc. (VNDA)
Q4 2023 Earnings Conference Call
February 07, 2024 04:30 PM ET
Company Participants
Kevin Moran - Chief Financial Officer
Mihael Polymeropoulos - President, Chief Executive Officer & Chairman
Tim Williams - General Counsel
Conference Call Participants
Andrew Tsai - Jefferies
Presentation
Operator
Good afternoon. My name is Jeannie and I will be your conference operator today. At this time, I would like to welcome everyone to the Q4 2023 Vanda Pharmaceuticals Inc. Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]
Thank you. I would like now to turn the call over to Kevin Moran, Vanda's Chief Financial Officer. Mr. Moran, you may begin your conference.
Kevin Moran
Thank you, Jeannie. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceuticals' fourth quarter and full year 2023 performance. Our fourth quarter and full year 2023 results were released this afternoon and are available on the SEC's EDGAR system and on our website, www.vandapharma.com . In addition, we are providing live and archived versions of this conference call on our website.
Joining me on today's call is Dr. Mihael Polymeropoulos, our President, Chief Executive Officer and Chairman of the Board; and Tim Williams, our General Counsel....
Read the full article on Seeking Alpha
For further details see:
Vanda Pharmaceuticals Inc. (VNDA) Q4 2023 Earnings Call Transcript